Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas AnalgesiaDermatologyMedical DeviceNeuroscienceOncology & HematologyPediatricsRare DiseaseOtherCOVID-19Cell & Gene TherapyWomen's HealthDiagnosticsReal-World & Late Phase By functional area All functional areas Clinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 Why Have Cancer Treatment Vaccines Fallen Short? By Premier Research June 15, 2017 Consulting 4 Obstacles to Collecting Quality Data in Psychiatric Drug Trials By Krista Armstrong June 13, 2017 Consulting Distinctive Characteristics of Fibromyalgia Patients By Scott Millard June 12, 2017 Consulting 4 Historical Orphan Drug Development Barriers, Have We Broken Through? By Juliet Moritz June 8, 2017 Clinical ResearchPhase 1 - Phase 4 Wearable Wrist Sensors Enable Detection of Stress, Seizures, and Pain By Premier Research June 2, 2017 Clinical ResearchPhase 1 - Phase 4 Considering iRECIST Guidance in Evaluating Solid Tumors By Premier Research June 1, 2017 Previous 1 …34 35 36 37 38 … 46 Next × ALSO OF INTERESTGene Therapy 101: From the 1960s to TodayNostalgia or Shell Shock? Assessing PTSD Is a...Key Considerations When Designing a Phase 1...
